Merck Enters into Exclusive Global License Agreement with SciBrunch Therapeutics for SPR2015, an Investigational Oral KRAS G12D Inhibitor
Investing News Network
2026-09-28T16:08:31Z
$148.78 (0.54%)
Look this symbol up in Slack with /ticker MRK. How to get stock tickers in Slack.
About Merck & Company Inc
Healthcare
Loading chart…
Key Data
OPEN
$148.06
DAY RANGE
$147.48 - $149.98
52 WEEK RANGE
$76.16 - $156.0
MARKET CAP
$367065793000
VOLUME
8292483
AVERAGE VOLUME
Performance
Trade Day Range
$147.48
LOW
$149.98
HIGH
52 Week Range
$76.16
LOW
$156.0
HIGH
Trade Now
Using this link to sign up for Robinhood
Using this link to sign up for M1 Finance
Or this link to sign up for WeBull
Recent News
Merck closes SciBrunch KRAS licence for up to US$2.13B
Mugglehead Investment Magazine
2026-09-28T14:42:00Z
Gilead’s HIV Concentration or Pfizer’s Patent Cliff: Which Risk is Easier to Own?
Yahoo Finance
2026-09-27T16:09:00Z
Get MRK quotes in Slack with /ticker MRK.
